Silo Pharma, Inc.
SILO
$0.45
$0.00-0.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.11M | -1.20M | -1.03M | -1.73M | -928.80K |
| Total Depreciation and Amortization | 2.90K | 2.50K | 3.10K | 3.10K | 3.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 568.20K | 16.50K | -2.90K | 0.00 | 0.00 |
| Change in Net Operating Assets | -416.20K | -99.90K | -609.00K | 810.10K | -420.80K |
| Cash from Operations | -955.50K | -1.29M | -1.64M | -917.40K | -1.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.50K | 388.10K | 871.40K | -37.70K | -40.40K |
| Cash from Investing | -95.50K | 388.10K | 871.40K | -37.70K | -40.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 634.90K | 2.09M | -- | 0.00 | 1.74M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 634.90K | 2.09M | -- | 0.00 | 1.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -416.00K | 1.20M | -768.90K | -955.10K | 354.60K |